LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

Alere Strengthens Core Strategy Through Two New Transactions

Alere, a leader in rapid diagnostics, continues to strengthen focus on its core business strategy through an agreement to sell BBI Group and an acquisition of US Diagnostics.   More...
09 Aug 2015

Cancer Genetics Expands Access to Proprietary Diagnostics Through Agreement with Harvard Pilgrim

Under the terms of a new agreement between Cancer Genetics and Harvard Pilgrim Healthcare, a health care network covering over one million people throughout Massachusetts, Connecticut, and Maine, CGI will offer its cancer diagnostic services to individuals covered under Harvard Pilgrim plans.  More...
02 Aug 2015

QIAGEN Expands Diagnostics Menu in Partnership with Seegene

In a new collaboration, Seegene will use its proprietary next-generation qPCR technology in developing new multiplex assays for the flagship platform of Qiagen. More...
13 Jul 2015

Next Generation Sequencing Provides Responsiveness for Identifying Resistant Pathogens

According to a new market analysis, next generation sequencing may impact the infectious diseases IVD sector by bypassing some of the downside of PCR-based testing, as NGS can provide more flexibility and responsiveness in identification of new pathogenic strains.  More...
06 Jul 2015

Hitachi High-Tech and QIAGEN Partner to Advance Diagnostics

Hitachi High-Technologies Corporation and QIAGEN N.V. have entered into a long-term strategic collaboration involving initiatives to deliver important advances in molecular testing.  More...
05 Jul 2015

Cloud-Based Systems Becoming Key Pillar in eHealth Strategy

Cloud-based laboratory information management systems are becoming a key pillar in Europe’s e-Health strategy as data-management solutions for modern testing will generate more demand for these systems.  More...
28 Jun 2015

Advanced NGS Partnership Paves Way for More Accessible Personalized Medicine in Cancer

New next generation sequencing test panels have been developed to provide more affordable advanced NGS testing that can help doctors choose the most effective cancer treatments based on tumor type and an individual’s genetic profile, an important step towards making personalized medicine broadly accessible. First launch is of a NGS colon cancer test panel.  More...
24 May 2015
Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
6 Part Hematology Analyzer with RET + IPF
Mispa HX 88


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.